HL Financial Services LLC lowered its stake in Clorox Co. (NYSE:CLX) by 43.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,583 shares of the company’s stock after selling 5,861 shares during the period. HL Financial Services LLC’s holdings in Clorox were worth $1,049,000 at the end of the most recent quarter.
Several other hedge funds have also recently bought and sold shares of CLX. Bank of Montreal Can purchased a new stake in Clorox during the second quarter valued at about $53,902,000. Prudential Financial Inc. raised its stake in Clorox by 209.8% in the first quarter. Prudential Financial Inc. now owns 540,279 shares of the company’s stock valued at $68,107,000 after buying an additional 365,910 shares in the last quarter. BlackRock Institutional Trust Company N.A. raised its stake in Clorox by 7.5% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 4,504,422 shares of the company’s stock valued at $567,827,000 after buying an additional 313,224 shares in the last quarter. BlackRock Group LTD raised its stake in Clorox by 18.2% in the first quarter. BlackRock Group LTD now owns 1,592,689 shares of the company’s stock valued at $200,775,000 after buying an additional 245,650 shares in the last quarter. Finally, Bessemer Group Inc. raised its stake in Clorox by 446.4% in the first quarter. Bessemer Group Inc. now owns 276,686 shares of the company’s stock valued at $34,879,000 after buying an additional 226,050 shares in the last quarter. Institutional investors and hedge funds own 70.26% of the company’s stock.
Clorox Co. (NYSE:CLX) traded down 0.66% during midday trading on Monday, hitting $125.69. 773,925 shares of the stock traded hands. Clorox Co. has a 52 week low of $113.37 and a 52 week high of $140.47. The stock’s 50-day moving average price is $128.79 and its 200 day moving average price is $130.13. The company has a market capitalization of $16.27 billion, a price-to-earnings ratio of 25.55 and a beta of 0.33.
Clorox (NYSE:CLX) last announced its quarterly earnings data on Wednesday, August 3rd. The company reported $1.26 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.28 by $0.02. The business earned $1.60 billion during the quarter, compared to the consensus estimate of $1.58 billion. Clorox had a return on equity of 296.91% and a net margin of 11.25%. The company’s revenue was up 2.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.44 earnings per share. On average, equities research analysts predict that Clorox Co. will post $5.49 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Monday, November 14th. Investors of record on Wednesday, October 26th will be issued a dividend of $0.80 per share. The ex-dividend date of this dividend is Monday, October 24th. This represents a $3.20 dividend on an annualized basis and a yield of 2.55%. Clorox’s dividend payout ratio is currently 64.91%.
Several brokerages recently commented on CLX. Atlantic Securities raised shares of Clorox from a “hold” rating to a “buy” rating and set a $144.00 price objective for the company in a research note on Friday, September 16th. Goldman Sachs Group Inc. reissued a “neutral” rating and issued a $130.00 price objective on shares of Clorox in a research note on Thursday, August 4th. Citigroup Inc. increased their price objective on shares of Clorox from $134.00 to $144.00 and gave the company a “neutral” rating in a research note on Monday, August 8th. Zacks Investment Research raised shares of Clorox from a “hold” rating to a “buy” rating and set a $148.00 price objective for the company in a research note on Monday, August 8th. Finally, Deutsche Bank AG reissued a “hold” rating and issued a $134.00 price objective (up previously from $130.00) on shares of Clorox in a research note on Sunday, July 24th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $128.90.
In related news, EVP Laura Stein sold 38,882 shares of the company’s stock in a transaction on Friday, September 2nd. The shares were sold at an average price of $131.69, for a total transaction of $5,120,370.58. Following the completion of the sale, the executive vice president now directly owns 48,501 shares in the company, valued at approximately $6,387,096.69. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, COO Nikolaos A. Vlahos sold 925 shares of the company’s stock in a transaction on Wednesday, August 10th. The shares were sold at an average price of $133.07, for a total transaction of $123,089.75. The disclosure for this sale can be found here. Corporate insiders own 2.09% of the company’s stock.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co. (NYSE:CLX).
Receive News & Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related companies with MarketBeat.com's FREE daily email newsletter.